165 related articles for article (PubMed ID: 2277141)
41. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis.
Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
Br J Dermatol; 1987 Apr; 116(4):503-10. PubMed ID: 3495286
[TBL] [Abstract][Full Text] [Related]
42. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporin in psoriasis: pathophysiology and experimental data.
Mozzanica N; Pigatto PD; Finzi AF
Dermatology; 1993; 187 Suppl 1():3-7. PubMed ID: 8103687
[TBL] [Abstract][Full Text] [Related]
44. [The skin as an immunological organ].
Bjerke JR
Tidsskr Nor Laegeforen; 2002 Mar; 122(8):793-6. PubMed ID: 12092071
[TBL] [Abstract][Full Text] [Related]
45. The immunologic basis for the treatment of psoriasis with new biologic agents.
Krueger JG
J Am Acad Dermatol; 2002 Jan; 46(1):1-23; quiz 23-6. PubMed ID: 11756941
[TBL] [Abstract][Full Text] [Related]
46. Cyclosporine for the treatment of psoriasis.
Brown MD; Gupta AK; Ellis CN; Cooper KD; Fisher GJ; Voorhees JJ
Transplant Proc; 1988 Jun; 20(3 Suppl 4):26-31. PubMed ID: 3381279
[No Abstract] [Full Text] [Related]
47. Cyclosporine in lamellar ichthyosis.
Ho VC; Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Voorhees JJ
Arch Dermatol; 1989 Apr; 125(4):511-4. PubMed ID: 2649010
[TBL] [Abstract][Full Text] [Related]
48. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
[TBL] [Abstract][Full Text] [Related]
50. Rapid occurrence of nodular cutaneous T-lymphocyte infiltrates with cyclosporine therapy.
Brown MD; Ellis CN; Billings J; Cooper KD; Baadsgaard O; Headington JT; Voorhees JJ
Arch Dermatol; 1988 Jul; 124(7):1097-100. PubMed ID: 3260470
[TBL] [Abstract][Full Text] [Related]
51. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis.
Prens EP; van Joost T; Hegmans JP; t Hooft-Benne K; Ysselmuiden OE; Benner R
J Am Acad Dermatol; 1995 Dec; 33(6):947-53. PubMed ID: 7490364
[TBL] [Abstract][Full Text] [Related]
52. Interactions of epidermal cells and T cells in inflammatory skin diseases.
Baadsgaard O; Fisher GJ; Voorhees JJ; Cooper KD
J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1312-6; discussion 1316-7. PubMed ID: 2277140
[TBL] [Abstract][Full Text] [Related]
53. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
54. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
[TBL] [Abstract][Full Text] [Related]
55. Keratinocytes derived from late-onset-psoriasis skin do not impair Langerhans cell migration.
Eaton LH; Dearman RJ; Kimber I; Griffiths CEM
Br J Dermatol; 2018 Nov; 179(5):1208-1209. PubMed ID: 29923325
[No Abstract] [Full Text] [Related]
56. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis.
Alshenawy HA; Hasby EA
Cell Immunol; 2011; 269(2):115-9. PubMed ID: 21470599
[TBL] [Abstract][Full Text] [Related]
57. Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation.
Nickoloff BJ; Griffiths CE
J Invest Dermatol; 1990 Nov; 95(5 Suppl):35S-37S. PubMed ID: 16788628
[TBL] [Abstract][Full Text] [Related]
58. Cyclosporine improves psoriasis in a double-blind study.
Ellis CN; Gorsulowsky DC; Hamilton TA; Billings JK; Brown MD; Headington JT; Cooper KD; Baadsgaard O; Duell EA; Annesley TM
JAMA; 1986 Dec; 256(22):3110-6. PubMed ID: 3023712
[TBL] [Abstract][Full Text] [Related]
59. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of sialyl Lewisx antigen in the skin and the sera of patients with psoriasis vulgaris.
Ohta K; Furukawa F; Fujita M; Kashihara-Sawami M; Horiguchi Y; Ueda M; Kurokawa S; Takigawa M; Imamura S
J Dermatol; 1996 Feb; 23(2):95-9. PubMed ID: 8839235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
